Pronto disponible para inscripción
This study will open for enrollment soon. Please contact the study team for more information and check back frequently.

KiteLock in Kids with CVC - Clinical Trial

What is the Purpose of this Study?

Some kids need a special tube called a central line to get medicine and food. But when the tube isn't being used, it can get blocked or infected. To help stop this, doctors use a liquid called a locking solution.

In this study, kids will be randomly placed into one of two groups:

- Group 1 will use the regular locking liquid called heparin.

- Group 2 will use a new liquid called Kitelock.

Both groups will use their locking liquid every day. They'll also have check-ups, blood tests, and keep a daily diary. The study will last about 1 year and include 6 in-person visits and 10 phone or video visits.

What is the Condition Being Studied?

PREVENTING CENTRAL VENOUS CATHETER

OCCLUSIONS IN CHILDREN WITH INTESTINAL FAILURE

Who Can Participate in the Study?

Who can join this study:

- Kids who have a serious stomach problem called intestinal failure and need special nutrition through a tube.

- They must be older than 4 weeks but were diagnosed before turning 18.

- They must have a special kind of tube called a central line, which helps give them medicine and nutrients.

Grupo etario
Niños

What is Involved?

Doctors are doing a study to learn more about a new liquid called KiteLock. It's used to keep special tubes (called central lines) clean and safe for kids who have serious stomach problems and need help getting food and medicine.

KiteLock has something called tetrasodium EDTA in it, and doctors want to see if it works better than the regular liquid called heparin. The goal is to find out which one helps stop clogs and infections in the tubes more safely and effectively.

Study Details

Full Title
Safety And Effectiveness Of 4% Tetrasodium Ethylenediaminetetraacetic Acid Catheter Lock Solution in Preventing Central Venous Catheter Occlusions in Children with Intestinal Failure: A Randomized Controlled Trial
Principal Investigator
Especialista en cirugía de trasplante de riñón y páncreas
Protocol Number
IRB: PRO00118105
NCT: NCT05879835
Phase
Phase N/A
ClinicalTrials.gov
Estado de inscripción
Pronto disponible para inscripción